The New Zealand Ministry of Health said on Monday that New Zealand had reported its first death related to Pfizer’s COVID19 vaccine after a woman had a rare side effect that caused inflammation of the myocardium.
When the report was released, the country was fighting the first outbreak of the Delta variant when the country had not dealt with the virus for nearly six months.
The Ministry of Health said in a statement: “This is New Zealand’s first death in a few days after vaccination related to Pfizer’s COVID19 vaccine,” the ministry said in a statement, but did not provide the woman’s age.
The Vaccine Control Team attributed the death to myocarditis, a rare but known side effect of Pfizer’s vaccine, the ministry added.
Myocarditis is inflammation of the heart muscle, which limits the ability of the organs to pump blood and may cause changes in the heart rhythm.
Pfizer said it recognizes that rare reports of myocarditis may occur after vaccination, but such side effects are extremely rare.
“Pfizer attaches great importance to adverse events that may be related to our vaccines,”
“We closely monitor all these events and collect relevant information to share with regulatory agencies around the world.”
The Ministry of Health stated that there are other medical issues that may affect the results after vaccination.
But he added that the benefits of vaccines outweigh the risks of side effects.
“The benefits of vaccinating the Pfizer COVID19 vaccine continue to greatly outweigh the risks of COVID19 infection and vaccine side effects (including myocarditis).”
Regulators from the United States, the European Union, and the World Health Organization stated that Pfizer and its partners BioNTech (22UAy.DE) and Moderna (MRNA.O) mRNA vaccine is associated with rare inflammation of the myocardium. or the lining around the heart, but the benefits outweigh any risks.
According to the WHO, these cases mainly affect young men, who are often milder and more treatable, but can cause serious illness.
The European Union Medicines Regulatory Agency stated on July 9 that 5 people in the European Economic Area died of side effects after receiving either of the two mRNA vaccines, all elderly or suffering from other diseases. More than 200 million doses of mRNA have been administered in this area.
New Zealand temporarily approved the use of the Pfizer / BioNTech, Janssen and AstraZeneca vaccines, but only the vaccines produced by Pfizer were approved for public release. Monday’s 53 new cases out of 4,444 brought the total number of New Zealand infections in the current outbreak to 562, as a nationwide lockdown was implemented this month to limit the spread of the Delta variant.